Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL FOR ACHIVING REMISSION IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS.

NCT04753775 is registered in ClinicalTrials.gov with Ospedale Sandro Pertini, Roma as lead sponsor.

NCT NCT04753775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04753775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL FOR ACHIVING REMISSION IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS.
Lead sponsor
Ospedale Sandro Pertini, Roma
Phase
Not applicable
Overall status
Completed
Start date
March 10, 2010
Completion date
May 10, 2010
Enrollment
44 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aloe vera gel, proctosigmoiditis, remission, trial, ulcerative colitis (uc)